ライフサイエンスコーパス: pars plana

1 ternally through 3 locations in the inferior pars plana.

2 , and this diminished posteriorly toward the pars plana.

3 s in the vitreous humor nor snowbanks on the pars plana.

4 balls in the vitreous or 2) snowbanks on the pars plana.

5 Fourteen black rabbits underwent a pars plana, 25-gauge, three-port vitrectomy by a single

6 In an unexpected finding, cysts in the pars plana also contained cells immunoreactive for a few

7 e or older, there were numerous cysts in the pars plana and in the peripheral retina.

8 tive into adulthood, marking the junction of pars plana and retinal margin as a niche capable of prod

9 The pars plana appears after birth and its length increases

10 of cases); intermediate uveitis affects the pars plana (attachment point of vitreous humor) and peri

11 In the pars plana, but not the retinal margin, cells remain pro

12 An emergency pars plana core vitrectomy was performed, and intraocula

13 ections of the peripheral retinal margin and pars plana from monkeys (Macaca nemestrina) between 1 an

14 the ciliary body process in 35% and into the pars plana in 10%.

15 Cysts form in the peripheral retina and pars plana in adult monkeys.

16 was barely detectable in cells isolated from pars plana in either cell layer.

17 Either a pars plana intravitreal bevacizumab or a viscoelastic-en

18 Trans-pars plana intravitreal injection of melphalan hydrochlo

19 of age, the nonpigmented inner layer of the pars plana is a pseudostratified columnar epithelium.

20 ve processes in the far periphery toward the pars plana labeled for SV2, suggesting that these proces

21 sular cataract extraction, and 40% following pars plana lensectomy.

22 uggesting that neurogenesis may occur in the pars plana of the adult primate.

23 pecimen contained tumor cells within sclera, pars plana, or pars plicata.

24 pertrophy of the retinal pigment epithelium, pars plana, ora serrata pearl, typical cystoid degenerat

25 roirideal diseases involving the sclerotomy, pars plana, pars plicata, ciliary sulcus, ciliary body,

26 ansporter protein in pars plicata PE than in pars plana PE.

27 njection (20-30 microg) by transconjunctival pars plana route with concomitant triple-freeze cryother

28 The cilium was removed through the pars plana sclerotomy with intraocular foreign body forc

29 and cable were introduced into the eye via a pars plana sclerotomy.

30 he time of subluxated lens extraction with a pars plana surgical approach yields favorable results in

31 return to the operating room and small-gauge pars plana techniques may reduce patient morbidity.

32 alone) was injected into the vitreous at the pars plana to a final concentration of 6 or 60 microM.

33 rosis included ciliary body (P = 0.0001) and pars plana to ora serrata (P < 0.0001) locations of ante

34 s Eye Bank were cut circumferentially at the pars plana to remove the anterior segment.

35 oduced into the monkey subretinal space by a pars plana transvitreal approach, the resultant detachme

36 gic examination, B-scan ultrasonography, and pars plana videoendoscopy were carried out to assess the

37 ship between different indications for trans pars plana vitrectomies (PPV's) and the intraocular pres

38 To determine the impact of total pars plana vitrectomies (PPVs) with peripheral shaving o

39 h intravitreal injections of antibiotics and pars plana vitrectomies with intravitreal antibiotics.

40 dogenous endophthalmitis (2/19, 10.5%), post-pars plana vitrectomy (1/19, 5.3%), and post-scleral buc

41 entions were phacoemulsification (20.8%) and pars plana vitrectomy (10.4%).

42 tial treatment was vitreous tap (49; 78%) or pars plana vitrectomy (14; 22%); all received intravitre

43 esent in 5 of 13 eyes (38%), including prior pars plana vitrectomy (3 eyes), history of retinal tear

44 of all patients had an ophthalmic procedure, pars plana vitrectomy (4.8%) being the most common one.

45 acuity (</=20/200 vs. >/=20/40, aHR, 1.47); pars plana vitrectomy (aHR, 1.87); history of OHT in the

46 of intravitreal antibiotics with or without pars plana vitrectomy (depending on the patient populati

47 reous was collected from patients undergoing pars plana vitrectomy (n = 84).

48 s associated with a higher rate of secondary pars plana vitrectomy (P = .009) and retinal detachment

49 quentially performed phacoemulsification and pars plana vitrectomy (phaco-PPV).

50 le scleral buckling (SB group - 12 eyes), or pars plana vitrectomy (PPV group - 21 eyes).

51 edictive of disease remission included prior pars plana vitrectomy (PPV) (hazard ratio [HR] [vs no PP

52 was done either by scleral buckling (SB) or pars plana vitrectomy (PPV) according to the topography

53 e differences in safety and efficacy between pars plana vitrectomy (PPV) alone and PPV with a supplem

54 genous retinal detachment (RRD) repair using pars plana vitrectomy (PPV) alone versus combined sclera

55 All cases were treated with pars plana vitrectomy (PPV) and a double silicone oil en

56 (30 women, 26 men) that underwent successful pars plana vitrectomy (PPV) and internal limiting membra

57 Nondiabetic eyes undergoing pars plana vitrectomy (PPV) and silicone oil tamponade w

58 eded-a standardised secondary procedure with pars plana vitrectomy (ppV) and subretinal rtPA.

59 All patients with RRD who underwent pars plana vitrectomy (PPV) between January 2013 and Dec

60 Venous air embolism (VAE) during pars plana vitrectomy (PPV) can occur owing to improper

61 tioning (FDP) for 3-6 months or longer after pars plana vitrectomy (PPV) combined with silicone oil (

62 Pars plana vitrectomy (PPV) continues to demonstrate eff

63 ctive case series of eyes undergoing primary pars plana vitrectomy (PPV) for common vitreoretinal ind

64 ane (ERM) and could influence the results of pars plana vitrectomy (PPV) for ERM removal in pseudopha

65 rence tomography data (iOCT) in all steps of pars plana vitrectomy (PPV) for non-RRD in MGS, in order

66 2) panretinal photocoagulation (PRP), or (3) pars plana vitrectomy (PPV) for PDR; and study eye chang

67 educed vertical metamorphopsia compared with pars plana vitrectomy (PPV) for primary rhegmatogenous r

68 dergone either pneumatic retinopexy (PnR) or pars plana vitrectomy (PPV) for rhegmatogenous retinal d

69 erwent 23 gauge transconjunctival sutureless pars plana vitrectomy (PPV) for serous macular detachmen

70 ministration in diabetic subjects undergoing pars plana vitrectomy (PPV) for severe manifestations of

71 in the 5 eyes with subhyaloid hemorrhage and pars plana vitrectomy (PPV) for the eyes with FTMH and e

72 utcomes of pneumatic retinopexy (PnR) versus pars plana vitrectomy (PPV) for the management of primar

73 rative diabetic retinopathy (PDR) undergoing pars plana vitrectomy (PPV) for vitreous hemorrhage (VH)

74 Previous pars plana vitrectomy (PPV) had been performed in 3 eyes

75 Pars plana vitrectomy (PPV) has been reported to reduce

76 (SB) in 49 (81.7%) eyes and combined SB and pars plana vitrectomy (PPV) in 11 (18.3%) eyes.

77 ar film osmolarity after micro-incision 25G+ pars plana vitrectomy (PPV) in a prospective study.

78 Pars plana vitrectomy (PPV) in eyes with history of reti

79 To report longer-term outcomes of 27-gauge pars plana vitrectomy (PPV) in eyes with posterior segme

80 effectiveness of prophylactic laser or early pars plana vitrectomy (PPV) in preventing retinal detach

81 Although pars plana vitrectomy (PPV) is a widely used treatment m

82 Primary pars plana vitrectomy (PPV) is often performed by vitreo

83 Pars plana vitrectomy (PPV) is preferred surgical proced

84 Pars plana vitrectomy (PPV) is the treatment of choice f

85 procedural code for intravitreal injections, pars plana vitrectomy (PPV) or laser treatment in their

86 genous retinal detachment (RRD) treated with pars plana vitrectomy (PPV) or PPV with scleral buckle (

87 in patients with IOFBs that we extracted by pars plana vitrectomy (PPV) over a 5-year period.

88 Patients with lensectomy or pars plana vitrectomy (PPV) prior to cataract surgery we

89 By comparison, vitreous samples obtained by pars plana vitrectomy (PPV) resulted in fungus-positive

90 When pars plana vitrectomy (PPV) was selected as the primary

91 Patients undergoing pars plana vitrectomy (PPV) were more likely to develop

92 ercent of eyes (n = 12) underwent an initial pars plana vitrectomy (PPV) with intravitreal antibiotic

93 Eyes undergoing pars plana vitrectomy (PPV) with membrane peel (MP) surg

94 e morphological and functional results after pars plana vitrectomy (PPV) with sulfur hexafluoride (SF

95 Of 3403 operations, 2693 (79.1%) were pars plana vitrectomy (PPV), 413 (12.1%) were retinopexy

96 Twenty-five percent of patients underwent pars plana vitrectomy (PPV), 50% underwent encircling sc

97 ocedures were compared, including repeat PR, pars plana vitrectomy (PPV), and combined scleral buckle

98 g a subsequent ocular intervention including pars plana vitrectomy (PPV), and complex RD repair withi

99 atic retinopexy (PR), scleral buckling (SB), pars plana vitrectomy (PPV), and laser prophylaxis were

100 B treatment prior to the study, a history of pars plana vitrectomy (PPV), and less than 1 year of fol

101 tear (GRT) more than 180 degrees by combined pars plana vitrectomy (PPV), encircling scleral buckle,

102 Surgical treatment involves pars plana vitrectomy (PPV), often combined with adjunct

103 umatic retinopexy (PR), scleral buckle (SB), pars plana vitrectomy (PPV), or combined PPV/SB and subs

104 Ds) can be treated with scleral buckle (SB), pars plana vitrectomy (PPV), or SB combined with PPV (PP

105 with sequential, bilateral RRD treated with pars plana vitrectomy (PPV), scleral buckle (SB), or PPV

106 retinal detachment (RD) surgical repair via pars plana vitrectomy (PPV), scleral buckle (SB), or PPV

107 with sequential, bilateral RRD treated with pars plana vitrectomy (PPV), scleral buckle (SB), or PPV

108 All patients undergoing pars plana vitrectomy (PPV), scleral buckling (SB), and

109 All operations included a pars plana vitrectomy (PPV)-41.1% with hexafluoroethane

110 luoropropane (C(3)F(8)) as an alternative to pars plana vitrectomy (PPV).

111 and 8 patients (67%) subsequently underwent pars plana vitrectomy (PPV).

112 Symptomatic patients underwent pars plana vitrectomy (PPV).

113 isorders are being successfully managed with pars plana vitrectomy (PPV).

114 rates of cataract extraction (CE) following pars plana vitrectomy (PPV).

115 is is a rare but devastating complication of pars plana vitrectomy (PPV).

116 isual impairment, necessitating a subsequent pars plana vitrectomy (PPV).

117 Patients with primary RRD operated with pars plana vitrectomy (PPV).

118 Twenty-six eyes underwent pars plana vitrectomy (PPV).

119 Intravitreal antifungal injection, pars plana vitrectomy (PPV).

120 All 15 eyes underwent pars plana vitrectomy (PPV): 6 for vitreous hemorrhage (

121 Interventions for RRD repair included pars plana vitrectomy (PPV; 15 patients), combined scler

122 , 2.2; 95% CI, 1.1-4.5) and combined SB plus pars plana vitrectomy (PPV; 68%; OR, 2.3; 95% CI, 1.1-5.

123 Patients who underwent standard or complex pars plana vitrectomy (PPV; Current Procedural Terminolo

124 ess was 72.4% with combined scleral buckling/pars plana vitrectomy (SB/PPV; N = 29) compared with 47.

125 cal intervention (pneumatic retinopexy [PR], pars plana vitrectomy [PPV], laser barricade, or scleral

126 Pars plana vitrectomy alone with complete drainage of su

127 chment, posterior synechia, and a history of pars plana vitrectomy also were associated with greater

128 Marfan syndrome, 2 (12%) were aphakic after pars plana vitrectomy and 4 (24%) were aphakic after sur

129 Associates, Newark, DE) suture and combined pars plana vitrectomy and compare predicted refractive o

130 sks, prognosis, and indications for diabetic pars plana vitrectomy and consider recent developments i

131 th microcystoid macular changes treated with pars plana vitrectomy and epiretinal and internal limiti

132 24 without glaucoma, underwent surgery with pars plana vitrectomy and epiretinal and internal limiti

133 Pars plana vitrectomy and ILM peeling have beneficial ef

134 Reasonable treatment options include pars plana vitrectomy and intra-ocular antibiotics with

135 sclerotomy versus scleral tunnel) at time of pars plana vitrectomy and intraocular foreign body remov

136 of the decentered/dislocated IOL along with pars plana vitrectomy and intrascleral fixation of a 3-p

137 costeroid therapy may resolve some entities, pars plana vitrectomy and lensectomy may be necessary to

138 Pars plana vitrectomy and lensectomy were performed, alo

139 rior chamber intraocular lens (PCIOL) before pars plana vitrectomy and lensectomy.

140 Patients underwent pars plana vitrectomy and peeling of the internal limiti

141 y and safety between combined and sequential pars plana vitrectomy and phacoemulsification for macula

142 Cataract formation can occur following pars plana vitrectomy and pneumatic retinopexy.

143 net capsulotomy, and 3 eyes (15.8%) required pars plana vitrectomy and posterior capsulotomy.

144 Pars plana vitrectomy and PPV-SB as the first procedure

145 Pars plana vitrectomy and PPV/SB were performed on 138 e

146 rates with other surgical techniques such as pars plana vitrectomy and scleral buckle.

147 and 56 weeks (follow-up, FUP) after 23 gauge pars plana vitrectomy and SF6 gas tamponade.

148 4 years of age with high-risk PRRD underwent pars plana vitrectomy and silicone oil injection with sc

149 The last patient had a pars plana vitrectomy and silicone oil instillation comb

150 Interventions included pars plana vitrectomy and silicone oil tamponade with or

151 Pars plana vitrectomy and tPA showed a clear advantage w

152 ntravitreal injection of antibiotics or with pars plana vitrectomy at least twice were included.

153 hage, anterior vitrectomy at primary repair, pars plana vitrectomy at primary repair, and lensectomy

154 vealed a trend toward a lower preference for pars plana vitrectomy compared to the West and South (P

155 Diabetic pars plana vitrectomy continues to advance with better a

156 urgery in both eyes and underwent unilateral pars plana vitrectomy due to postcataract endophthalmiti

157 tical coherence tomography in patients after pars plana vitrectomy due to postcataract endophthalmiti

158 y for accurate evaluation of the efficacy of pars plana vitrectomy for BRVO.

159 ew published studies that report outcomes of pars plana vitrectomy for complications of BRVO consist

160 included 20 eyes from 20 patients undergoing pars plana vitrectomy for complications of PDR.

161 Pars plana vitrectomy for diabetic macular edema and for

162 28 eyes in 20 patients (all male) underwent pars plana vitrectomy for intraocular hemorrhages second

163 s undergoing a standard 20-gauge or 23-gauge pars plana vitrectomy for intraocular hemorrhages second

164 Patients who underwent pars plana vitrectomy for macula-off rhegmatogenous reti

165 Patients underwent pars plana vitrectomy for MFS.

166 accurately assess the risks and benefits of pars plana vitrectomy for proliferative diabetic retinop

167 t underwent combined phacoemulsification and pars plana vitrectomy for retinal detachment and later s

168 ctive cohort study of 506 eyes who underwent pars plana vitrectomy for rhegmatogenous retinal detachm

169 ion was performed at the slit lamp or during pars plana vitrectomy for telangiectasia visible at the

170 ect; 1 of these patients required subsequent pars plana vitrectomy for worsening clinical course.

171 Five patients required pars plana vitrectomy for worsening vitritis.

172 Vitreous fluids were collected during 23G pars plana vitrectomy from 54 eyes of 54 patients with d

173 25-Gauge pars plana vitrectomy has evolved significantly since it

174 s in the culture group required a subsequent pars plana vitrectomy in 29 of 119 cases (24%) compared

175 nts, intravitreal antibiotics in 4 eyes, and pars plana vitrectomy in 4 eyes.

176 initial treatment in 57 of 63 (90%) eyes and pars plana vitrectomy in 6 of 63 (10%) eyes.

177 of the XEN stent in 5 patients (62.5%), and pars plana vitrectomy in 6 patients (75%).

178 on in 7 of 9 cases, removal of fibrosis with pars plana vitrectomy in all 9 patients, and implantatio

179 (1) phakic patients with history of pars plana vitrectomy in one eye as the only procedure;

180 olac 0.45%, 4 times daily, for 3 days before pars plana vitrectomy in the first 12 consecutive eyes.

181 elopment of suprachoroidal hemorrhage during pars plana vitrectomy include high myopia, history of pr

182 oscope-enabled intraoperative viewing during pars plana vitrectomy include posterior segment disease

183 udies will help dictate the future course of pars plana vitrectomy instrumentation.

184 Pars plana vitrectomy is associated with clinically mean

185 uring scleral fixation surgery combined with pars plana vitrectomy leads to significantly less RPB, a

186 A complete pars plana vitrectomy may be required in order to reposi

187 ears to be that scleral buckling and primary pars plana vitrectomy may yield comparable single-operat

188 94 of 436 eyes (21.6%) with mean BCVA before pars plana vitrectomy of 20/78 and final follow-up BCVA

189 The surgical management using pars plana vitrectomy offers the most effective approach

190 Pars plana vitrectomy offers theoretical advantages but

191 Pars plana vitrectomy plus SB yielded a significantly hi

192 Pars plana vitrectomy procedure has showed a better visu

193 Pars plana vitrectomy procedures between January 1, 2013

194 r regions (P < .01) and lower preference for pars plana vitrectomy relative to the South and West (P

195 Pars plana vitrectomy required a significantly higher nu

196 Previous scleral buckling or pars plana vitrectomy seem to have no impact on the succ

197 atomical alterations imposed by the previous pars plana vitrectomy surgery and the underlying vitreor

198 Pars plana vitrectomy surgery was performed for the prog

199 e is an uncommon but serious complication of pars plana vitrectomy that can be associated with a guar

200 groups: control subjects (n = 3) undergoing pars plana vitrectomy to remove an epiretinal membrane (

201 Pars plana vitrectomy usually was performed in patients

202 With regard to management, pars plana vitrectomy was associated with increased prob

203 Pars plana vitrectomy was frequently performed regardles

204 Pars plana vitrectomy was most common (49%), followed by

205 ents and final anatomical reattachment after pars plana vitrectomy was obtained in 100% of patients.

206 Pars plana vitrectomy was performed in 9 eyes (6%) with

207 Pars plana vitrectomy was performed in 94 of 436 eyes (2

208 A 25-gauge pars plana vitrectomy was performed in all cases, with a

209 A 23-gauge pars plana vitrectomy was performed with peeling of the

210 Next, a pars plana vitrectomy was performed, and the electrode a

211 equired repeat grafting, and in 6 of 8 eyes, pars plana vitrectomy was used to remove the dislocated

212 Subretinal injection with pars plana vitrectomy was well tolerated in this cohort.

213 Pars plana vitrectomy will probably remain the treatment

214 pathic macular holes that underwent 23-gauge pars plana vitrectomy with 2 cc pure SF6 gas tamponade.

215 Either pars plana vitrectomy with 24-gray EMB and ongoing pro r

216 year-old lady with a stage IV FTMH underwent pars plana vitrectomy with 25 gauge plus transconjunctiv

217 Participants underwent pars plana vitrectomy with a single 24-gray dose of epim

218 Participants underwent pars plana vitrectomy with a single 24-Gy dose of EMB de

219 All consecutive patients underwent pars plana vitrectomy with a superiorly based inverted I

220 More recently, pars plana vitrectomy with adventitial sheathotomy has a

221 Pars plana vitrectomy with creation of an inner retinal

222 In glaucomatous eyes, pars plana vitrectomy with epiretinal and internal limit

223 Lamellar macular hole surgery involves pars plana vitrectomy with epiretinal membrane or prolif

224 Pars plana vitrectomy with ERM removal and ILM peeling w

225 iterature of FIL SSF IOL opacification after pars plana vitrectomy with gas tamponade for retinal det

226 Ten patients who underwent standard 3-port pars plana vitrectomy with gas tamponade to repair rhegm

227 Surgeon method included 23-gauge or 25-gauge pars plana vitrectomy with induction of posterior vitreo

228 Pars plana vitrectomy with internal limiting membrane pe

229 Patients underwent pars plana vitrectomy with internal limiting membrane pe

230 etinopathy is now most frequently treated by pars plana vitrectomy with intraoperative peeling of mem

231 travitreal antibiotic injection (n = 12) and pars plana vitrectomy with intravitreal antibiotic injec

232 ntravitreal antibiotic injection (n = 5) and pars plana vitrectomy with intravitreal antibiotic injec

233 nal abscess is smaller than four disc areas, pars plana vitrectomy with intravitreal injection of ant

234 A pars plana vitrectomy with intravitreal injection of cef

235 orrhage presents a 76% increased profit over pars plana vitrectomy with laser, with equivalent functi

236 etinal membrane formation, for which she had pars plana vitrectomy with membrane peeling.

237 Pars plana vitrectomy with or without delamination/segme

238 7 patients with idiopathic ERM who underwent pars plana vitrectomy with peeling of the ERM from 2019

239 Combining pars plana vitrectomy with phacoemulsification and poste

240 Combined 23-gauge pars plana vitrectomy with phacoemulsification for prima

241 For eyes undergoing pars plana vitrectomy with scleral-sutured IOL implantat

242 received surgery (pneumatic retinopexy [PR], pars plana vitrectomy with silicone oil [PPV+SO], or scl

243 l detachment underwent an uneventful primary pars plana vitrectomy with silicone oil endotamponade on

244 Pars plana vitrectomy with SO tamponade with or without

245 genous retinal detachment underwent 23-gauge pars plana vitrectomy with subretinal fluid drainage thr

246 All patients underwent a pars plana vitrectomy with subretinal implantation of hu

247 Pars plana vitrectomy with supplemental SB was associate

248 gical treatments for sub macular hemorrhage, pars plana vitrectomy with tissue plasminogen activator

249 Eleven patients (85%) underwent a pars plana vitrectomy within 24 h.

250 omes and safety of transconjuctival 23-gauge pars plana vitrectomy(PPV) for removal of intraocular fo

251 ervention (intravitreal injection, laser, or pars plana vitrectomy).

252 study was to assess the surgical outcomes of pars plana vitrectomy, 180 degrees inferior retinotomy a

253 eripheral anterior synechia, 3 eyes previous pars plana vitrectomy, 2 eyes aphakia, and 1 eye each wi

254 veitis, 1 prior hydrocephalus, 1 uveitis and pars plana vitrectomy, and 1 juvenile open-angle glaucom

255 All 15 patients had prior pars plana vitrectomy, and 14 patients (93%) had no lens

256 tic patients undergoing cataract extraction, pars plana vitrectomy, and intravitreal injections and t

257 He had undergone pars plana vitrectomy, and SFIOL using silk sutures one-

258 tus, clear vitreous tap, cases not requiring pars plana vitrectomy, and those with Staphylococcus aur

259 ctors associated with IOP elevation included pars plana vitrectomy, contralateral IOP elevation (adju

260 dies show that particular surgeries, such as pars plana vitrectomy, Descemet stripping (automated) en

261 her pediatric ages), prior cataract surgery, pars plana vitrectomy, duration of uveitis >/=6 months,

262 cryotherapy, scleral buckling at the time of pars plana vitrectomy, external drainage of the subretin

263 ock hours, use of silicone oil tamponade for pars plana vitrectomy, history of choroidal detachment,

264 intervention without success; subsequently, pars plana vitrectomy, internal limiting membrane peel a

265 Fourteen eyes underwent pars plana vitrectomy, internal limiting membrane peelin

266 All patients underwent pars plana vitrectomy, internal limiting membrane peelin

267 uckle, pneumatic retinopexy, 25- or 27-gauge pars plana vitrectomy, or any combination of these techn

268 Intravitreal triamcinolone acetonide, pars plana vitrectomy, oral protein kinase C inhibitors

269 ntial to condense three separate procedures: pars plana vitrectomy, phacoemulsification, and YAG caps

270 The management options for VMT include pars plana vitrectomy, pneumatic vitreolysis, enzymatic

271 Following prior pars plana vitrectomy, pO(2) levels were significantly h

272 All eyes underwent pars plana vitrectomy, removal of any epiretinal membran

273 preference for retinal detachment repair by pars plana vitrectomy, scleral buckling, and pneumatic r

274 Prior to the invention of pars plana vitrectomy, such surgery was innovative, even

275 n eyes with suprachoroidal hemorrhage during pars plana vitrectomy, the final visual and anatomic out

276 Vitreous biopsy, followed by 25-gauge pars plana vitrectomy, was performed in the same sitting

277 he procedure was unsuccessful, necessitating pars plana vitrectomy, while in a case with proliferativ

278 atients with light perception should receive pars plana vitrectomy, while those with hand motion and

279 Pars plana vitrectomy-SB showed less improvement in visi

280 ge of sub-retinal fluid without the need for pars plana vitrectomy.

281 , or placebo 4 times daily for 3 days before pars plana vitrectomy.

282 4 eyes in 22 consecutive patients undergoing pars plana vitrectomy.

283 f patients undergoing cataract surgery after pars plana vitrectomy.

284 groups and subjected to standard three-port pars plana vitrectomy.

285 icenter trial compares scleral buckling with pars plana vitrectomy.

286 re indicated in several situations following pars plana vitrectomy.

287 treous samples were collected at the time of pars plana vitrectomy.

288 ften difficult to remove during conventional pars plana vitrectomy.

289 e to explant the XEN stent and perform early pars plana vitrectomy.

290 s detachment (PVD) is a critical step during pars plana vitrectomy.

291 tional intravitreal antibiotic injections or pars plana vitrectomy.

292 Most eyes (62%) underwent pars plana vitrectomy.

293 ed to define the subretinal space, following pars plana vitrectomy.

294 ution) intravitreally applied during routine pars plana vitrectomy.

295 ism and a patient with keratoconus following pars plana vitrectomy.

296 cluded: posterior dislocations necessitating pars plana vitrectomy; secondary implantations for aphak

297 ), secondary to multiple treatments (n = 7), pars-plana vitrectomy (n = 3), external-beam radiotherap

298 and 56 weeks (follow-up, FUP) after 23 gauge pars-plana vitrectomy and SF6 gas tamponade.

299 um diameter > 400 mum) treated with 25-gauge pars-plana vitrectomy with either complete ILM peeling (

300 Some of the cells surrounding cysts in the pars plana were also unexpectedly immunoreactive for ant